Bosmolisib

N/A

Report date: 2025/09/19 20:01:00
NME

Base Information

Drug NameBosmolisib
Drug Alias NameBR-101801BR-1018-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsHyperlipidemiasHypertensionWaldenstrom Macroglobulinemia +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoryung Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertensionWaldenstrom Macroglobulinemia +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A